Latest Industry Insights

As primary care physicians continue to see an increasing number of patients with fatty liver disease, it is important for them to be able to effectively triage these patients to ensure the best possible care. In this opinion piece, Dr. Tram Tran, Chief Medical Officer of Glympse, discusses the importance of early intervention and highlights the urgent need for effective diagnostic strategies.

In honor of International Day of Women and Girls in Science 2022, Technology Networks interviewed three women who have built successful careers within the scientific industry, to learn about their career paths and the reasons they chose to work in industry.

In this interview, we speak to Dr. Antal Szalay, CEO of Ultimate Medicine, about how his company helped establish that a microbiome metabolite can cause age-related memory loss.

Next-generation sequencing (NGS) has undoubtedly revolutionized the genomics field and thanks to technological advances in recent years, laboratories around the globe are now applying NGS to a wide variety of applications. However, library sample preparation remains a key bottleneck and researchers are now looking to adopt automation solutions to alleviate this pain point. Technology Networks recently spoke with Paul Lomax, product manager at SPT Labtech to learn more about firefly^®, the company’s new liquid handling platform for NGS library preparation.

Therapies are needed for patients with autoimmune disorders such as lupus. Technology Networks spoke to Cherie Ng, the senior director for research at Equillium, about how the first-in-class anti-CD6 therapy was designed.

Recent legislation changes by Health Canada have seen psychedelics become easier to prescribe for a range of mental health conditions. We spoke to Alexander Somjen, CEO of Origin Therapeutics, to find out what the impact of these changes will be for physicians, patients and providers.

In this interview, Dr. Ren discusses some of the challenges that currently exist when developing gene therapies and explores how Cyagen’s one-stop gene therapy platform can help to address them.

Technology Networks spoke with Michael Yang, president and chief executive officer of ViaCyte, to learn more about the development of a stem cell-derived therapy for the treatment of T1D and the technology behind it.

Technological innovations brought in as a result of COVID-19 could produce dramatic changes to how we do science. In this insight, Synthace co-founder Markus Gershater previews a cloud-first future for bioscience.

Technology Networks spoke to Jesse Harris to learn why spreadsheets can be a bottleneck for pharma research and explore how they compare to laboratory informatics tools.